The forecast for Blood and Blood Forming Organs Medicine use in Denmark shows a consistent, albeit modest, increase in Defined Daily Dosage (DDD) per thousand persons per day from 2024 through 2028. The year-on-year growth is steady, with an incremental rise from 122.5 units in 2024 to 125.6 units by 2028. This suggests a stable demand for these medicines, with a Compound Annual Growth Rate (CAGR) indicating a slight upward trend.
Looking ahead, factors such as demographic shifts, advances in medical treatments, and changes in healthcare policy could influence demand for these medicines. Increased awareness and diagnosis of blood disorders, aging population, and innovations in blood-related medical treatments are key trends to watch, as they may accelerate use and necessitate adjustments in healthcare planning and supply chain strategies.
